- Oops!Something went wrong.Please try again later.
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical studies. Northland Capital Markets upgraded the stock from Market Perform to Outperform.
Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) gained 74% to $8.04. Supernus Pharmaceuticals agreed to acquire Adamas Pharmaceuticals for $9.10 per share, or $450 million.
Flexion Therapeutics, Inc. (NASDAQ: FLXN) gained 60.9% to $9.30. Pacira BioSciences agreed to acquire Flexion Therapeutics for $8.50 per share in cash, plus one contingent value right (CVR) worth up to $8.00 per share in cash.
U.S. Well Services, Inc. (NASDAQ: USWS) jumped 29.6% to $3.1099 in sympathy with the price of oil amid increased demand and limited supply.
EZFill Holdings Inc. (NASDAQ: EZFL) surged 17% to $4.0790 after the company announced it has purchased 33 additional fuel trucks, more than tripling the size of its delivery fleet.
Blue Apron Holdings, Inc. (NYSE: APRN) gained 16.2% to $7.95.
Gaotu Techedu Inc. (NASDAQ: GOTU) rose 16% to $3.9250.
Ocular Therapeutix, Inc. (NASDAQ: OCUL) surged 15% to $11.21. Traders circulated Oct. 7 FDA approval for the company’s Dextenza.
Katapult Holdings, Inc. (NASDAQ: KPLT) rose 13.2% to $5.18. Katapult Holdings became an Accelerate partner in the Adobe Exchange Program.
DatChat, Inc. (NASDAQ: DATS) gained 13% to $13.24.
TETRA Technologies, Inc. (NYSE: TTI) rose 12.8% to $3.86 in sympathy with the price of oil amid increased demand and limited supply.
Innoviz Technologies Ltd. (NASDAQ: INVZ) gained 12.3% to $5.22.
Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) surged 11.3% to $14.25.
Nutriband Inc. (NASDAQ: NTRB) shares gained 10.5% to $7.40 after dropping over 14% on Friday.
Trevi Therapeutics, Inc. (NASDAQ: TRVI) gained 10% to $1.33 after the company filed Friday to withdraw its offering of shares.
Matinas BioPharma Holdings, Inc. (NASDAQ: MTNB) rose 8.5% to $1.1501.
Liquidia Corporation (NASDAQ: LQDA) rose 7.9% to $7.40 after the company received favorable ruling in Inter Partes Review against United Therapeutics patent.
AIkido Pharma Inc. (NASDAQ: AIKI) shares rose 6.8% to $0.9289. HC Wainwright & Co. initiated coverage on AIkido Pharma with a Buy rating and announced a price target of $2.
Cipher Mining Inc. (NASDAQ: CIFR) shares dropped 18.8% to $6.41.
AeroCentury Corp. (NYSE: ACY) shares fell 14% to $52.44.
SecureWorks Corp. (NASDAQ: SCWX) shares declined 13.3% to $20.13.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) dropped 11.3% to $4.92 after jumping around 45% on Friday.
PagSeguro Digital Ltd. (NASDAQ: PAGS) fell 11.1% to $32.51 after dropping 19% on Friday.
MeaTech 3D Ltd. (NASDAQ: MITC) dropped 10.3% to $7.62. Meatech 3D recently said it is partnering with a collective led by Ashton Kutcher and Guy Oseary, together with strategic players like Effie Epstein, to accelerate growth in developing, commercializing cultured meat production technologies.
eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) fell 9.7% to $10.69. eFFECTOR Therapeutics, in collaboration with Baylor College of Medicine, recently announced the presentation of new positive data for zotatifin in animal models of triple-negative breast cancer (TNBC).
Hyliion Holdings Corp. (NYSE: HYLN) dropped 9% to $7.11 after UBS downgraded the stock from Neutral to Sell and lowered its price target from $14 to $5.
BEST Inc. (NYSE: BEST) fell 8.2% to $1.8997.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) dropped 7.5% to $9.56.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.